Adage Capital Partners’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $37M | Buy |
70,301
+2,000
| +3% | +$1.12M | 0.05% | 345 |
|
|
2026
Q1 | $38.4M | Buy |
68,301
+16,254
| +31% | +$10.4M | 0.06% | 307 |
|
|
2025
Q4 | $35.2M | Buy |
52,047
+16,377
| +46% | +$11.2M | 0.05% | 330 |
|
|
2025
Q3 | $22.8M | Sell |
35,670
-23,531
| -40% | -$14.3M | 0.04% | 423 |
|
|
2025
Q2 | $31.8M | Buy |
+59,201
| New | +$28.3M | 0.05% | 333 |
|
|
2025
Q1 | – | Sell |
-28,967
| Closed | -$12M | – | 892 |
|
|
2024
Q4 | $12M | Sell |
28,967
-4,978
| -15% | -$2.18M | 0.02% | 566 |
|
|
2024
Q3 | $17.1M | Sell |
33,945
-18,933
| -36% | -$9.2M | 0.03% | 491 |
|
|
2024
Q2 | $25.8M | Sell |
52,878
-3,889
| -7% | -$1.95M | 0.05% | 369 |
|
|
2024
Q1 | $30.7M | Sell |
56,767
-13,934
| -20% | -$7.61M | 0.06% | 350 |
|
|
2023
Q4 | $39.2M | Sell |
70,701
-38,055
| -35% | -$17.9M | 0.08% | 251 |
|
|
2023
Q3 | $47.6M | Buy |
108,756
+26,055
| +32% | +$13M | 0.11% | 209 |
|
|
2023
Q2 | $41.5M | Sell |
82,701
-200
| -0.2% | -$95.8K | 0.09% | 230 |
|
|
2023
Q1 | $41.5M | Sell |
82,901
-1,300
| -2% | -$622K | 0.09% | 253 |
|
|
2022
Q4 | $34.4M | Sell |
84,201
-600
| -0.7% | -$233K | 0.08% | 286 |
|
|
2022
Q3 | $27.6M | Buy |
84,801
+12,300
| +17% | +$4.52M | 0.07% | 320 |
|
|
2022
Q2 | $25.4M | Sell |
72,501
-16,000
| -18% | -$6.52M | 0.06% | 350 |
|
|
2022
Q1 | $48.4M | Sell |
88,501
-61,900
| -41% | -$32.6M | 0.09% | 220 |
|
|
2021
Q4 | $99M | Buy |
150,401
+58,800
| +64% | +$36.9M | 0.18% | 118 |
|
|
2021
Q3 | $57M | Sell |
91,601
-1,188
| -1% | -$798K | 0.11% | 189 |
|
|
2021
Q2 | $58.6M | Sell |
92,789
-1,300
| -1% | -$718K | 0.11% | 186 |
|
|
2021
Q1 | $46M | Sell |
94,089
-800
| -0.8% | -$401K | 0.09% | 222 |
|
|
2020
Q4 | $47.4M | Sell |
94,889
-309
| -0.3% | -$138K | 0.1% | 213 |
|
|
2020
Q3 | $37.4M | Sell |
95,198
-3,100
| -3% | -$1.15M | 0.09% | 228 |
|
|
2020
Q2 | $32.5M | Buy |
98,298
+25,168
| +34% | +$7.29M | 0.08% | 273 |
|
|
2020
Q1 | $17.7M | Sell |
73,130
-25,789
| -26% | -$6.73M | 0.05% | 347 |
|
|
2019
Q4 | $25.8M | Sell |
98,919
-5,700
| -5% | -$1.5M | 0.06% | 331 |
|
|
2019
Q3 | $28.4M | Buy |
104,619
+25
| +0% | +$6.96K | 0.07% | 294 |
|
|
2019
Q2 | $28.8M | Sell |
104,594
-62,606
| -37% | -$15.4M | 0.07% | 299 |
|
|
2019
Q1 | $37.4M | Buy |
167,200
+119,106
| +248% | +$24.6M | 0.09% | 255 |
|
|
2018
Q4 | $8.95M | Sell |
48,094
-138,849
| -74% | -$28.5M | 0.02% | 529 |
|
|
2018
Q3 | $46.7M | Buy |
186,943
+46,500
| +33% | +$11.3M | 0.1% | 236 |
|
|
2018
Q2 | $30.6M | Buy |
140,443
+103,286
| +278% | +$21.3M | 0.07% | 304 |
|
|
2018
Q1 | $7.11M | Sell |
37,157
-25,243
| -40% | -$4.66M | 0.02% | 606 |
|
|
2017
Q4 | $9.76M | Buy |
+62,400
| New | +$9.82M | 0.02% | 573 |
|
|
2017
Q3 | – | Sell |
-110,300
| Closed | -$17.8M | – | 730 |
|
|
2017
Q2 | $17.8M | Sell |
110,300
-16,900
| -13% | -$2.74M | 0.04% | 435 |
|
|
2017
Q1 | $19.7M | Buy |
+127,200
| New | +$17.5M | 0.05% | 404 |
|
|
2015
Q2 | – | Sell |
-120,000
| Closed | -$9.27M | – | 743 |
|
|
2015
Q1 | $9.27M | Sell |
120,000
-120,000
| -50% | -$9.34M | 0.02% | 562 |
|
|
2014
Q4 | $17.8M | Sell |
240,000
-160,000
| -40% | -$11.2M | 0.04% | 428 |
|
|
2014
Q3 | $23.6M | Buy |
400,000
+200,000
| +100% | +$12.6M | 0.06% | 358 |
|
|
2014
Q2 | $13.4M | Buy |
200,000
+140,000
| +233% | +$8.9M | 0.03% | 476 |
|
|
2014
Q1 | $3.64M | Buy |
+60,000
| New | +$3.57M | 0.01% | 617 |
|
Other funds holding IDXX
Adage Capital Partners's IDXX Position: Q2 2026 in Review
Adage Capital Partners increased its Idexx Laboratories (IDXX) stake by 2.9% in Q2 2026, buying an estimated $1.12M and bringing the position to 70,301 shares worth $37M. The position accounts for 0.05% of the portfolio, ranked #345.
Adage Capital Partners first reported a position in IDXX in Q1 2014 and has held it in 41 quarters since. The position peaked at $99M in Q4 2021. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Adage Capital Partners held 70,301 shares of Idexx Laboratories worth $37M as of Q2 2026.
- Adage Capital Partners bought 2,000 Idexx Laboratories shares in Q2 2026, an estimated $1.12M.
- Idexx Laboratories made up 0.05% of Adage Capital Partners's portfolio in Q2 2026, its #345 holding.
- Adage Capital Partners first reported a position in Idexx Laboratories in Q1 2014 and has held it in 41 quarters since.
- Adage Capital Partners's Idexx Laboratories position peaked at $99M in Q4 2021.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.